retatrutide obesity trial results type 2 diabetes phase 2 2024 ada demonstrate benefits of in obesity, diabetes, NASH Efficacy and Safety of Retatrutide – Retatrutide Shines in Obesity Trial

Following bacterial or viral infections, increased expression of self-antigens may occur, causing abnormal MHC expression and disrupting immune tolerance (Pu And Zhang 2024)

HIV infection causes a gradual decrease in CD4+ T cell count over time

women who did not use a GLP-1

Ultraviolet and high-energy visible light (particularly wavelengths below 450 nm) can cleave peptide bonds and oxidise methionine residues within the amino acid chain

developed an oxidation-reduction sensitive micelle POEG-p-2DG based on 2-DG (a glycolytic inhibitor) prodrug, which can serve as a carrier for V-9302

Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology